Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.
With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financing
rounds.
Their companies are based in Europe allowing easy interaction with management.
They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Website:www.vesaliusbiocapital.com
Industries:
Biometrics
Biotechnology
Collaborative Consumption
Life Science
Collaboration
Health Care
Analytics
Artificial Intelligence
Data Visualization
Medical
Software
Advanced Materials
Chemical
Chemical Engineering
mHealth
Therapeutics
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
Strassen, Canton of Luxembourg, Luxembourg
Contact information:
